Coughlin Timothy
CIK: 0001376043
Director
Primary company: NEUROCRINE BIOSCIENCES INC (NBIX)
Coughlin Timothy is a corporate insider at NEUROCRINE BIOSCIENCES INC (NBIX) filing SEC Form 4 transactions. 133 transactions across 5 companies, totaling $237,497 in purchases and $11,190,513 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 16,000 | $8.51 | $136K | 16,000 | 6/9/2026 Filed: 6/9/2026 | Filing → | |
| Award | 16,000 | $8.51 | $136K | 16,000 | 6/9/2026 Filed: 6/9/2026 | Filing → | |
| Award | 8,000 | - | - | 16,000 | 6/9/2026 Filed: 6/9/2026 | Filing → | |
| Award | 8,000 | - | - | 8,000 | 6/9/2026 Filed: 6/9/2026 | Filing → | |
| Exercise | 10,000 | - | - | 0 | 10/31/2025 Filed: 11/4/2025 | Filing → | |
| Exercise | 8,000 | - | - | 0 | 10/31/2025 Filed: 11/4/2025 | Filing → | |
| Sale | 18,000 | $35.03 | $631K | 55,500 | 10/31/2025 Filed: 11/4/2025 | Filing → | |
| Exercise | 10,000 | $17.44 | $174K | 73,500 | 10/31/2025 Filed: 11/4/2025 | Filing → | |
| Exercise | 8,000 | $16.33 | $131K | 63,500 | 10/31/2025 Filed: 11/4/2025 | Filing → | |
ADC Therapeutics SA ADCT | Award | 80,000 | - | - | 80,000 | 6/3/2025 Filed: 6/5/2025 | Filing → |
ADC Therapeutics SA ADCT | Award | 40,000 | - | - | 40,000 | 6/3/2025 Filed: 6/5/2025 | Filing → |
| Award | 19,500 | - | - | 19,500 | 5/15/2025 Filed: 5/16/2025 | Filing → | |
| Award | 6,500 | - | - | 55,500 | 5/15/2025 Filed: 5/16/2025 | Filing → | |
aTYR PHARMA INC ATYR | Award | 50,000 | - | - | 50,000 | 5/1/2025 Filed: 5/2/2025 | Filing → |
| Award | 40,000 | - | - | 40,000 | 6/7/2024 Filed: 6/11/2024 | Filing → | |
aTYR PHARMA INC LIFE | Purchase | 50,000 | $1.75 | $88K | 56,000 | 5/30/2024 Filed: 6/3/2024 | Filing → |
aTYR PHARMA INC LIFE | Award | 24,000 | - | - | 24,000 | 5/22/2024 Filed: 5/23/2024 | Filing → |
| Award | 19,500 | - | - | 19,500 | 5/8/2024 Filed: 5/10/2024 | Filing → | |
| Award | 6,500 | - | - | 49,000 | 5/8/2024 Filed: 5/10/2024 | Filing → | |
| Award | 40,000 | $0.00 | $0 | 40,000 | 6/6/2023 Filed: 6/7/2023 | Filing → |
Type
Award
Shares
16,000
Price
$8.51
Value
$136K
Type
Award
Shares
16,000
Price
$8.51
Value
$136K
Type
Award
Shares
8,000
Price
-
Value
-
Type
Award
Shares
8,000
Price
-
Value
-
Type
Exercise
Shares
10,000
Price
-
Value
-
Type
Exercise
Shares
8,000
Price
-
Value
-
Type
Sale
Shares
18,000
Price
$35.03
Value
$631K
Type
Exercise
Shares
10,000
Price
$17.44
Value
$174K
Type
Exercise
Shares
8,000
Price
$16.33
Value
$131K
ADC Therapeutics SA
ADCT
Type
Award
Shares
80,000
Price
-
Value
-
ADC Therapeutics SA
ADCT
Type
Award
Shares
40,000
Price
-
Value
-
Type
Award
Shares
19,500
Price
-
Value
-
Type
Award
Shares
6,500
Price
-
Value
-
aTYR PHARMA INC
ATYR
Type
Award
Shares
50,000
Price
-
Value
-
Type
Award
Shares
40,000
Price
-
Value
-
aTYR PHARMA INC
LIFE
Type
Purchase
Shares
50,000
Price
$1.75
Value
$88K
aTYR PHARMA INC
LIFE
Type
Award
Shares
24,000
Price
-
Value
-
Type
Award
Shares
19,500
Price
-
Value
-
Type
Award
Shares
6,500
Price
-
Value
-
Type
Award
Shares
40,000
Price
$0.00
Value
$0
AI Agent
Try asking...